BUTORPHANOL Drug Patent Profile
✉ Email this page to a colleague
When do Butorphanol patents expire, and what generic alternatives are available?
Butorphanol is a drug marketed by Baxter Hlthcare Corp, Hikma, Hikma Farmaceutica, Hospira, Apotex, and Rising. and is included in fourteen NDAs.
The generic ingredient in BUTORPHANOL is butorphanol tartrate. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the butorphanol tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Butorphanol
A generic version of BUTORPHANOL was approved as butorphanol tartrate by HIKMA on August 12th, 1998.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BUTORPHANOL?
- What are the global sales for BUTORPHANOL?
- What is Average Wholesale Price for BUTORPHANOL?
Summary for BUTORPHANOL
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 14 |
| Drug Prices: | Drug price information for BUTORPHANOL |
| DailyMed Link: | BUTORPHANOL at DailyMed |


